top of page

Email:  bd@sidmexinovia.com | Phone:  +918866862020

  • Whatsapp
  • Instagram
  • Facebook
  • X
  • LinkedIn

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Alunbrig 90mg Tablet

Alunbrig 90mg Tablet

Manufacturer/Marketed By : TAKEDA PHARMACEUTICALS INDIA PVT LTD

$1606.97 $1414.13

Alunbrig 90mg Tablet is an anticancer agent used to treat non-small cell lung cancer (NSCLC), containing the active ingredient Brigatinib. It belongs to a class of drugs called tyrosine kinase...

Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.

BRIGATINIB

Active Pharmaceutical Ingredient

Alunbrig 90mg Tablet

SKU TAKEDA PHARMACEUTICALS INDIA PVT LTD
Prix d’origine

1 606,97$

Prix promotionnel

1 414,13$

Alunbrig 90mg Tablet is an anticancer agent used to treat non-small cell lung cancer (NSCLC), containing the active ingredient Brigatinib. It belongs to a class of drugs called tyrosine kinase inhibitors (TKIs) that block abnormal proteins responsible for cancer cell growth. Alunbrig 90mg Tablet prescribed for patients with ALK-positive (anaplastic lymphoma kinase-positive) NSCLC who have shown disease progression or intolerance to previous ALK inhibitors. It helps prevent cancer cells from multiplying and spreading by targeting specific enzymes involved in tumor growth. This drug is contraindicated in individuals with known hypersensitivity to Alunbrig 90mg Tablet or its components. Stop using it and consult your doctor immediately if you experience allergic reactions such as rash, swelling, or breathing difficulty. If you are pregnant, planning pregnancy, or suspect pregnancy, consult your doctor before taking Alunbrig 90mg Tablet, as it may cause serious harm to the fetus. Similarly, consult your physician if you are breastfeeding or planning to breastfeed. Your doctor will assess your medical history and other medicines to ensure safe use. Alunbrig price varies by retailer and location.

Active Pharmaceutical Ingredient

BRIGATINIB

Uses

• Treatment of ALK-positive non-small cell lung cancer (NSCLC)
• Managing disease progression in patients previously treated with other ALK inhibitors
• Reducing tumor growth and preventing metastasis

Benefits

Alunbrig 90mg Tablet is used in the treatment of non-small cell lung cancer (NSCLC), particularly in patients with specific genetic mutations. It works by targeting and blocking abnormal proteins that promote the growth and spread of cancer cells. By interfering with these signals, this medicine helps slow down or stop the progression of the disease. It may also help shrink tumors and relieve symptoms associated with lung cancer. Regular use as prescribed supports better disease control and improves overall quality of life.

Side Effects

Common side effects:

Most Common Side Effects

• Lung problems (pneumonitis, interstitial lung disease)
• Liver enzyme abnormalities
• Severe allergic reactions (rash, swelling, difficulty breathing)
• High blood pressure
• Visual disturbances

Common Side Effects

• Nausea
• Fatigue
• Diarrhea
• Increased blood pressure
• Cough

How To Use

Take exactly as prescribed by your oncologist

Safety Advice

• Pregnancy: It is recommended to avoid this medication during pregnancy as Alunbrig 90mg Tablet may cause fetal harm. Inform your doctor if you are pregnant, suspect pregnancy, or planning to become pregnant before starting treatment.
• Breast Feeding: It is unknown whether Alunbrig 90mg Tablet passes into breast milk. Consult your doctor before using this medicine while breastfeeding.
• Lungs: Alunbrig 90mg Tablet may cause serious lung-related side effects such as interstitial lung disease or pneumonitis. Inform your doctor if you have a history of lung problems or experience shortness of breath before starting treatment.
• Liver: Alunbrig 90mg Tablet is metabolized by the liver and may cause elevated liver enzymes or liver dysfunction. Inform your doctor if you have liver disease before starting treatment.
• Alcohol: There is limited data on the safety of alcohol use with Alunbrig 90mg Tablet . It may increase the risk of side effects such as drowsiness or liver issues. Please consult your physician.
• Driving: Alunbrig 90mg Tablet may cause dizziness or fatigue. Avoid driving or operating heavy machinery until you understand how the drug affects you.

Disclaimer

Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.

Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.

All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.

Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.

bottom of page